SolasCure enrols first patient in a next phase II clinical trial to advance Aurase Wound Gel

FHS
March 17, 2025
11:36 am

SOLASCURE Ltd (SolasCure), a biotechnology company developing a novel treatment to transform chronic wound healing, today announced the initiation of a new Phase II clinical trial, CLEANVLU2.

Emory Health Taps DrFirst to Leverage Clinical-Grade AI for Medication Adherence & Affordability

What You Should Know: – Emory Healthcare, a comprehensive academic health system in Georgia, is collaborating with healthcare technology pioneer DrFirst to help patients access

November 2, 2023

Q&A with Obesity Society’s CEO as the field prepares for next-gen meds

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

November 2, 2024

Healthcare AI Trends: Balancing Innovation and Patient Safety

Dr. Heather Bassett, Chief Medical Officer with Xsolis As healthcare organizations explore the potential of AI, they face a complex challenge: balancing innovation with caution. While some embrace AI as a

January 22, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.